NK cells as powerful therapeutic tool in cancer immunotherapy

D. Hanahan, Hallmarks of Cancer: New dimensions. Cancer Discov. 12, 31–46 (2022)

Article  CAS  PubMed  Google Scholar 

A.K. Singh, J.P. McGuirk, CAR T cells: continuation in a revolution of immunotherapy. Lancet Oncol. 21, e168–e178 (2020)

Article  CAS  PubMed  Google Scholar 

S. Bagchi, R. Yuan, E.G. Engleman, Immune Checkpoint inhibitors for the treatment of Cancer: clinical impact and mechanisms of response and resistance. Annu. Rev. Pathol. 16, 223–249 (2021)

Article  CAS  PubMed  Google Scholar 

O. Demaria, S. Cornen, M. Daëron, Y. Morel, R. Medzhitov, E. Vivier, Harnessing innate immunity in cancer therapy. Nature. 574, 45–56 (2019)

Article  CAS  PubMed  Google Scholar 

Y. Yang, Cancer immunotherapy: harnessing the immune system to battle cancer. J. Clin. Invest. 125, 3335–3337 (2015)

Article  PubMed  PubMed Central  Google Scholar 

A. Kumar, C.A. Swain, L.A. Shevde, Informing the new developments and future of cancer immunotherapy. Cancer Metastasis Rev. 40, 549–562 (2021)

Article  CAS  PubMed  Google Scholar 

M.G. Morvan, L.L. Lanier, NK cells and cancer: you can teach innate cells new tricks. Nat. Rev. Cancer. 16, 7–19 (2016)

Article  CAS  PubMed  Google Scholar 

T. Timonen, J.R. Ortaldo, R.B. Herberman, Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153, 569–582 (1981)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Anft, P. Netter, D. Urlaub, I. Prager, S. Schaffner, C. Watzl, NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production. Cell. Mol. Immunol. 17, 347–355 (2020)

Article  CAS  PubMed  Google Scholar 

F. Fang, S. Xie, M. Chen, Y. Li, J. Yue, J. Ma et al., Advances in NK cell production. Cell. Mol. Immunol. 19, 460–481 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.A. Caligiuri, Human natural killer cells. Blood. 112, 461–469 (2008)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Fauriat, E.O. Long, H.-G. Ljunggren, Y.T. Bryceson, Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood. 115, 2167–2176 (2010)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Yu, A.G. Freud, M.A. Caligiuri, Location and cellular stages of NK cell development. Trends Immunol. 34 (2013). https://doi.org/10.1016/j.it.2013.07.005

P. Dogra, C. Rancan, W. Ma, M. Toth, T. Senda, D.J. Carpenter et al., Tissue determinants of human NK Cell Development, function, and Residence. Cell. 180, 749–763e13 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, L.L. Lanier et al., Innate or adaptive immunity? The Example of Natural Killer cells. Science. 331, 44–49 (2011)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Kumar, Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology. 154, 383–393 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

F. Nimmerjahn, J.V. Ravetch, Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34–47 (2008)

Article  CAS  PubMed  Google Scholar 

J.S. Orange, Formation and function of the lytic NK-cell immunological synapse. Nat. Rev. Immunol. 8, 713–725 (2008)

Article  CAS  PubMed  PubMed Central  Google Scholar 

I. Prager, C. Watzl, Mechanisms of natural killer cell-mediated cellular cytotoxicity. J. Leukoc. Biol. 105, 1319–1329 (2019)

Article  CAS  PubMed  Google Scholar 

M.J. Smyth, E. Cretney, J.M. Kelly, J.A. Westwood, S.E.A. Street, H. Yagita et al., Activation of NK cell cytotoxicity. Mol. Immunol. 42, 501–510 (2005)

Article  CAS  PubMed  Google Scholar 

I. Prager, C. Liesche, van H. Ooijen, D. Urlaub, Q. Verron, N. Sandström et al., NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing. J. Exp. Med. 216, 2113–2127 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Piccioli, S. Sbrana, E. Melandri, N.M. Valiante, Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335–341 (2002)

Article  CAS  PubMed  PubMed Central  Google Scholar 

B. Cózar, M. Greppi, S. Carpentier, E. Narni-Mancinelli, L. Chiossone, E. Vivier, Tumor-infiltrating natural killer cells. Cancer Discov. 11, 34–44 (2021)

Article  PubMed  Google Scholar 

E. Schlecker, N. Fiegler, A. Arnold, P. Altevogt, S. Rose-John, G. Moldenhauer et al., Metalloprotease-mediated Tumor Cell Shedding of B7-H6, the ligand of the natural killer cell–activating receptor NKp30. Cancer Res. 74, 3429–3440 (2014)

Article  CAS  PubMed  Google Scholar 

F. Ghiringhelli, C. Ménard, M. Terme, C. Flament, J. Taieb, N. Chaput et al., CD4 + CD25 + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 202, 1075–1085 (2005)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Á. Teijeira, S. Garasa, M. Gato, C. Alfaro, I. Migueliz, A. Cirella et al., CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce Neutrophil Extracellular traps that interfere with Immune cytotoxicity. Immunity. 52, 856–871e8 (2020)

Article  CAS  PubMed  Google Scholar 

X. Zheng, Y. Qian, B. Fu, D. Jiao, Y. Jiang, P. Chen et al., Mitochondrial fragmentation limits NK cell-based Tumor immunosurveillance. Nat. Immunol. 20, 1656–1667 (2019)

Article  CAS  PubMed  Google Scholar 

J. Ni, X. Wang, A. Stojanovic, Q. Zhang, M. Wincher, L. Bühler et al., Single-cell RNA sequencing of Tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1α unleashes NK Cell activity. Immunity. 52, 1075–1087e8 (2020)

Article  CAS  PubMed  Google Scholar 

S.E. Keating, V. Zaiatz-Bittencourt, R.M. Loftus, C. Keane, K. Brennan, D.K. Finlay et al., Metabolic reprogramming supports IFN-γ production by CD56bright NK cells. J. Immunol. 196, 2552–2560 (2016)

Article  CAS  PubMed  Google Scholar 

M.G. Badur, C.M. Metallo, Reverse engineering the cancer metabolic network using flux analysis to understand drivers of human Disease. Metab. Eng. 45, 95–108 (2018)

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif